355 related articles for article (PubMed ID: 8801862)
1. Effects of LDL on intracellular free calcium and nitric oxide-dependent cGMP formation in porcine endothelial cells.
Pohl U; Heydari N; Galle J
Atherosclerosis; 1995 Oct; 117(2):169-78. PubMed ID: 8801862
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
Boulanger C; Schini VB; Moncada S; Vanhoutte PM
Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
[TBL] [Abstract][Full Text] [Related]
3. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production.
Jaimes EA; Sweeney C; Raij L
Hypertension; 2001 Oct; 38(4):877-83. PubMed ID: 11641302
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells.
Graier WF; Myers PR; Rubin LJ; Adams HR; Parker JL
Circ Res; 1994 Oct; 75(4):659-68. PubMed ID: 7923612
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
Tanner FC; Noll G; Boulanger CM; Lüscher TF
Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic changes in rat and guinea pig coronary microvascular endothelium after culture: loss of nitric oxide synthase activity.
Lang D; Bell JP; Bayraktutan U; Small GR; Shah AM; Lewis MJ
Cardiovasc Res; 1999 Jun; 42(3):794-804. PubMed ID: 10533620
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
Chin JH; Azhar S; Hoffman BB
J Clin Invest; 1992 Jan; 89(1):10-8. PubMed ID: 1309534
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of EDRF release by native low-density lipoprotein from cultured porcine endothelial cells through intracellular mechanisms.
Ezaki M; Ikeda M; Tomita I; Tomita T
J Cardiovasc Pharmacol; 1994 Oct; 24(4):552-8. PubMed ID: 7528837
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
10. Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP.
Buchan KW; Martin W
Br J Pharmacol; 1991 Oct; 104(2):361-6. PubMed ID: 1665733
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
Kuhn M; Otten A; Frölich JC; Förstermann U
J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
[TBL] [Abstract][Full Text] [Related]
12. Glucose elevations alter bradykinin-stimulated intracellular calcium accumulation in cultured endothelial cells.
Pieper GM; Dondlinger L
Cardiovasc Res; 1997 Apr; 34(1):169-78. PubMed ID: 9217887
[TBL] [Abstract][Full Text] [Related]
13. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
Schmidt K; Klatt P; Mayer B
Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
[TBL] [Abstract][Full Text] [Related]
14. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
Lamontagne D; Pohl U; Busse R
Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
[TBL] [Abstract][Full Text] [Related]
15. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
16. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
Crack P; Cocks T
Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
[TBL] [Abstract][Full Text] [Related]
17. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability.
Vergnani L; Hatrik S; Ricci F; Passaro A; Manzoli N; Zuliani G; Brovkovych V; Fellin R; Malinski T
Circulation; 2000 Mar; 101(11):1261-6. PubMed ID: 10725285
[TBL] [Abstract][Full Text] [Related]
18. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries.
Holzmann S; Kukovetz WR; Windischhofer W; Paschke E; Graier WF
J Cardiovasc Pharmacol; 1994 May; 23(5):747-56. PubMed ID: 7521457
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells.
Bogle RG; Coade SB; Moncada S; Pearson JD; Mann GE
Biochem Biophys Res Commun; 1991 Oct; 180(2):926-32. PubMed ID: 1659406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
